EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level  |
|---|
   1.14.14.73 | Alzheimer Disease |
25796175 |
CYP2J2 rs890293 polymorphism is associated with susceptibility to Alzheimer's disease in the Chinese Han population. |
unassigned |
0 |
| 1.14.14.73 | Alzheimer Disease |
27396818 |
Gene- gene interaction between CYP2J2 and PPAR -? gene on late-onset Alzheimer's disease in the eastern Chinese Han population. |
diagnostic usage
ongoing research
therapeutic application
unassigned |
1
2
1
0 |
| 1.14.14.73 | Aortic Aneurysm, Abdominal |
23446230 |
CYP2J2 Overexpression Increases EETs and Protects against Angiotensin II-Induced Abdominal Aortic Aneurysm in Mice. |
therapeutic application
unassigned |
1
0 |
| 1.14.14.73 | Arrhythmias, Cardiac |
24023684 |
CYP2J2 Overexpression Protects against Arrhythmia Susceptibility in Cardiac Hypertrophy. |
causal interaction
therapeutic application
unassigned |
1
2
0 |
| 1.14.14.73 | Atherosclerosis |
26859195 |
CYP2J2 Overexpression Increases EETs and Protects Against HFD-induced Atherosclerosis in ApoE-/- Mice. |
causal interaction
ongoing research
therapeutic application
unassigned |
2
3
1
0 |
| 1.14.14.73 | Atherosclerosis |
28000856 |
CYP2J2 participates in atherogenesis by mediating cell proliferation, migration and foam cell formation. |
ongoing research
unassigned |
4
0 |
| 1.14.14.73 | Brain Infarction |
23041291 |
Cytochrome P450 2J2 is protective against global cerebral ischemia in transgenic mice. |
causal interaction
ongoing research
therapeutic application
unassigned |
3
2
4
0 |
| 1.14.14.73 | Brain Ischemia |
23041291 |
Cytochrome P450 2J2 is protective against global cerebral ischemia in transgenic mice. |
causal interaction
ongoing research
therapeutic application
unassigned |
3
2
4
0 |
| 1.14.14.73 | Breast Neoplasms |
32354111 |
In-Depth Characterization of EpiIntestinal Microtissue as a Model for Intestinal Drug Absorption and Metabolism in Human. |
therapeutic application
unassigned |
2
0 |
| 1.14.14.73 | Breast Neoplasms |
32920985 |
Impact of gene polymorphisms in drug-metabolizing enzymes and transporters on trough concentrations of rivaroxaban in patients with atrial fibrillation. |
ongoing research
unassigned |
2
0 |
